Larvol Delta - NCI202303181-Glofitamab-With-Obinutuzumab-Venetoclax-and-Lenalidomide-for-the-Treatment-of-Patients-With-Newly-Diagnosed-High-Risk-Mantle-Cell-Lymphoma

Venclexta (venetoclax) - Roche, AbbVie

lenalidomide - Generic mfg.

Gazyva (obinutuzumab) - Roche, Biogen

Columvi (glofitamab-gxbm) - Roche

http://clinicaltrials.gov/ct2/show/NCT05861050

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next